Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2 diabetes
Abstract
Backgrounds
Whether insulin resistance and not obesity per se is the major contributor to clinical outcomes associated with obesity has not been fully established. This study evaluated in a group of obese Brazilians of multiethnic origin to what extent the prevalence of hypertension and other cardiometabolic risk factors varies as a function of the degree of insulin sensitivity.
Methods
The study involved 118 individuals (mean age of 44
±
12 years; BMI
=
38.6
±
7.9 kg/m2) without evidence of diabetes or cardiovascular disease. Insulin resistance was assessed by HOMA-IR index, which was used to stratify patients into tertiles.
Results
The mean HOMA-IR in tertile 1, the most insulin-sensitive group, was 2.7
±
0.8 and in tertile 3, the most insulin-resistant group, 9.1
±
2.4 (P
<
0.001). Mean arterial pressure showed a linear and significant variation across the HOMA-IR tertiles 1, 2, and 3 (94.3
±
11.7; 98.7
±
11.4; 105.0
±
12.4 mm Hg), as did fasting plasma glucose (93.6
±
12.1; 98.1
±
12.7; 100.0
±
11.0 mg/dL), uric acid (4.7
±
1.4; 5.9
±
1.9; 6.3
±
1.4 mg/dL), HDL-cholesterol (48.1
±
11.6; 46.5
±
10.5; 42.2
±
8.0 mg/dL), and plasma adiponectin (7.8
±
3.3; 7.0
±
2.8; 6.3
±
6.5 µg/mL), respectively. The results indicated that 27.5% of our patients had dysglicemia, 28.2% had hypertriglyceridemia, and 30.7% had arterial hypertension in the most insulin-sensitive tertile, when compared with 51%, 53.8% and 79.4%, respectively, in the most insulin-resistant tertile. A stepwise regression analysis showed that only HOMA-IR and age independently affected the risk for increased systolic blood pressure.
Conclusion
In conclusion, our findings have shown that the risk of developing essential hypertension, type 2 diabetes, and cardiovascular disease is accentuated in obese individuals who are also more insulin resistant.
Keywords: Insulin-resistance, Multiethnic obese, Hypertension, Type 2 diabetes
To access this article, please choose from the options below
PII: S0953-6205(08)00274-4
doi:10.1016/j.ejim.2008.09.009
© 2008 European Federation of Internal Medicine. Published by Elsevier Inc All rights reserved.
